Summary
- Current Price
- As of today, MAZE price is $27.18, down -1.75% on
- Current Price All-Time High
- MAZE price is currently -49.34% below its historical high of $53.65 set on
- Market Cap
- MAZE current market cap is $2B, up +157.91% over the past 365 days
- Revenue
- MAZE current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for MAZE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Maze Therapeutics, Inc. |
| Ticker | NASDAQ: MAZE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | mazetx.com |
| Employees | 125 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $27.18 | |
| Price, 1D Change | -1.75% | |
| $2B | ||
| - | ||
| - | ||
| 1.05 | ||
| $0.00 | ||
| Revenue, 1Y Change | -100.00% | |
| -$2.66 | ||
| EPS, 1Y Change | -3,516.07% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.66 | ||
| EPS Estimate | -$2.75 | N/A |
| EPS Est. Change | -3.30% | N/A |
| $0.00 | ||
| Revenue Estimate | $20.00M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $27.18 | |
| Price Target | $55.00 | - |
| Price Tgt. Change | +102.35% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$20.10 | $0.08 | +100.39% | |
| -$3.07 | -$2.66 | +13.42% | |
| -$2.75 | N/A | -3.30% | |
| -$3.16 | N/A | -18.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $125.63M | $167.50M | +33.33% | |
| - | $0.00 | - | |
| $20.00M | N/A | - | |
| $8.85M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $27.18 | |
| $34.50 | ||
| $27.60 | ||
| $29.23 | ||
| $28.13 | ||
| -$0.20 | ||
| 1.05 | ||
| $1.49 | ||
| 45.00 | ||
| 35.16% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.66 | ||
| -$2.40M | ||
| - | ||
| -$142.90M | ||
| - | ||
| -$131.12M | ||
| - | ||
| -$140.50M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.07 | ||
| 15.50 | ||
| 15.50 | ||
| - | ||
| - | ||
| 19.56 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 75.49 | ||
| 4.42 | ||
| -9.24 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $354.97M | ||
| $341.92M | ||
| $397.13M | ||
| $349.72M | ||
| $42.16M | ||
| $22.56M | ||
| $23.31M | ||
| $4.80M | ||
| $1.79M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $131.12M | ||
| $140.50M | ||
| $2.40M | ||
| $0.00 | ||
| $2.40M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$111.94M | ||
| -$170.96M | ||
| $275.34M | ||
| $794.00K | ||
| -$112.73M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| BTIG | → | |
| Truist Securities | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Truist Securities | ||
| Wedbush | → | |
| Mizuho | ||
| BTIG | → | |
| Guggenheim | → |
Analyst sentiment
Institutional ownership
Screeners with MAZE
FAQ
- What is the ticker symbol for Maze Therapeutics, Inc.?
- The ticker symbol for Maze Therapeutics, Inc. is NASDAQ:MAZE
- Does Maze Therapeutics, Inc. pay dividends?
- No, Maze Therapeutics, Inc. does not pay dividends
- What sector is Maze Therapeutics, Inc. in?
- Maze Therapeutics, Inc. is in the Healthcare sector
- What industry is Maze Therapeutics, Inc. in?
- Maze Therapeutics, Inc. is in the Biotechnology industry
- What country is Maze Therapeutics, Inc. based in?
- Maze Therapeutics, Inc. is headquartered in United States
- When did Maze Therapeutics, Inc. go public?
- Maze Therapeutics, Inc. initial public offering (IPO) was on January 31, 2025
- Is Maze Therapeutics, Inc. in the S&P 500?
- No, Maze Therapeutics, Inc. is not included in the S&P 500 index
- Is Maze Therapeutics, Inc. in the NASDAQ 100?
- No, Maze Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Maze Therapeutics, Inc. in the Dow Jones?
- No, Maze Therapeutics, Inc. is not included in the Dow Jones index
- When was Maze Therapeutics, Inc. last earnings report?
- Maze Therapeutics, Inc.'s most recent earnings report was on August 12, 2026
- When does Maze Therapeutics, Inc. report earnings?
- The date for Maze Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MAZE Official Website www.mazetx.com
- MAZE Profile on Yahoo Finance finance.yahoo.com/quote/MAZE
- MAZE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/maze